Guttman-McCabe Christopher

Track

Insider profile

Performance

Overall performance
2.4
Performance over holding periods
2.4
30 days 90 days 120 days
Average return -25% 8.2% 15.1%
Success rate 4% 68% 82%
Transactions
7 0% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Guttman-McCabe Christopher's trades of Anterix Inc.'s stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
US Anterix Inc. (ATEX)
Transaction date
Sale
Price
424.86
Quantity 29,242 +41.8%
Value US$1,752,611
US Anterix Inc. (ATEX)
Transaction date
Sale
Price
303.67
Quantity 9,489 +48.8%
Value US$4,980,054
US Anterix Inc. (ATEX)
Transaction date
Sale
Price
82.83
Quantity 79,808 +47.8%
Value US$3,211,835
US Anterix Inc. (ATEX)
Transaction date
Sale
Price
93.59
Quantity 5,372 -7.9%
Value US$502,746
US Anterix Inc. (ATEX)
Transaction date
Proposed sale
Price
92.36
Quantity 23,439
Value US$2,164,838
US Anterix Inc. (ATEX)
Transaction date
Sale
Price
84.29
Quantity 13,324 -14.6%
Value US$1,123,077
US Anterix Inc. (ATEX)
Transaction date
Sale
Price
83.72
Quantity 16,381 -15.2%
Value US$1,371,471
US Anterix Inc. (ATEX)
Transaction date
Sale
Price
82.27
Quantity 26,411 -19.7%
Value US$2,172,904
US Anterix Inc. (ATEX)
Transaction date
Sale
Price
81.32
Quantity 35,321 -20.9%
Value US$2,872,431
US Anterix Inc. (ATEX)
Transaction date
Proposed sale
Price
81.75
Quantity 122,852
Value US$10,042,746
US Anterix Inc. (ATEX)
Transaction date
Sale
Price
36.21
Quantity 8,332 -13.3%
Value US$301,660
US Anterix Inc. (ATEX)
Transaction date
Sale
Price
44.26
Quantity 7,538 -17.1%
Value US$333,594
US Anterix Inc. (ATEX)
Transaction date
Sale
Price
29.75
Quantity 1,590 -3.5%
Value US$47,302
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2026-08-27 2026-08-25
US Anterix Inc. (ATEX)
S Sale
29,242 +41.8%
424.86
US$1,752,611 		29,242 +41.8% 424.86 US$1,752,611
2026-08-27 2026-08-25
US Anterix Inc. (ATEX)
S Sale
9,489 +48.8%
303.67
US$4,980,054 		9,489 +48.8% 303.67 US$4,980,054
2026-08-27 2026-08-25
US Anterix Inc. (ATEX)
S Sale
79,808 +47.8%
82.83
US$3,211,835 		79,808 +47.8% 82.83 US$3,211,835
2026-08-27 2026-08-25
US Anterix Inc. (ATEX)
S Sale
5,372 -7.9%
93.59
US$502,746 		5,372 -7.9% 93.59 US$502,746
2026-08-25 2026-08-25
US Anterix Inc. (ATEX)
PrS Proposed sale
23,439
92.36
US$2,164,838 		23,439 92.36 US$2,164,838
2026-06-17 2026-06-15
US Anterix Inc. (ATEX)
S Sale
13,324 -14.6%
84.29
US$1,123,077 		13,324 -14.6% 84.29 US$1,123,077
2026-06-17 2026-06-15
US Anterix Inc. (ATEX)
S Sale
16,381 -15.2%
83.72
US$1,371,471 		16,381 -15.2% 83.72 US$1,371,471
2026-06-17 2026-06-15
US Anterix Inc. (ATEX)
S Sale
26,411 -19.7%
82.27
US$2,172,904 		26,411 -19.7% 82.27 US$2,172,904
2026-06-17 2026-06-15
US Anterix Inc. (ATEX)
S Sale
35,321 -20.9%
81.32
US$2,872,431 		35,321 -20.9% 81.32 US$2,872,431
2026-06-15 2026-06-15
US Anterix Inc. (ATEX)
PrS Proposed sale
122,852
81.75
US$10,042,746 		122,852 81.75 US$10,042,746
2022-11-28 2022-11-25
US Anterix Inc. (ATEX)
S Sale
8,332 -13.3%
36.21
US$301,660 		8,332 -13.3% 36.21 US$301,660
2021-02-19 2021-02-18
US Anterix Inc. (ATEX)
S Sale
7,538 -17.1%
44.26
US$333,594 		7,538 -17.1% 44.26 US$333,594
2020-12-16 2020-12-16
US Anterix Inc. (ATEX)
S Sale
1,590 -3.5%
29.75
US$47,302 		1,590 -3.5% 29.75 US$47,302